In this issue:
NAPOLI 3: HR-QoL & performance status
Cachexia & survival with nab-paclitaxel/gemcitabine ± tocilizumab in advanced pancreatic cancer
An engineered oncolytic herpes simplex virus to treat advanced HCC
Mitochondrial DNA copy numbers in gastric cancer tissue
ImmunoTACE: dendritic cell vaccination + conditioning cyclophosphamide + TACE in HCC
Income, treatment & survival in rural patients with upper GI malignancies
Liver cancer risks with oral contraceptives
GI cancer management in Spain during the COVID-19 pandemic
Please login below to download this issue (PDF)